Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy.

Agrillo A, Filiaci F, Ramieri V, Riccardi E, Quarato D, Rinna C, Gennaro P, Cascino F, Mitro V, Ungari C.

Eur Rev Med Pharmacol Sci. 2012 Nov;16(12):1741-7.

2.

Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.

Vescovi P, Nammour S.

Minerva Stomatol. 2010 Apr;59(4):181-203, 204-13. Review. English, Italian.

PMID:
20360666
3.

Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery?

Atalay B, Yalcin S, Emes Y, Aktas I, Aybar B, Issever H, Mandel NM, Cetin O, Oncu B.

Lasers Med Sci. 2011 Nov;26(6):815-23. doi: 10.1007/s10103-011-0974-2.

PMID:
21809068
4.

Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis.

Agrillo A, Ungari C, Filiaci F, Priore P, Iannetti G.

J Craniofac Surg. 2007 Sep;18(5):1071-5.

PMID:
17912085
5.

[A case report - bisphosphonate-related osteonecrosis of the jaw(stage 0)successfully treated with sitafloxacin].

Ikeda T, Kohno N.

Gan To Kagaku Ryoho. 2012 Dec;39(13):2573-5. Japanese.

PMID:
23235183
6.

Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy.

Lee JJ, Cheng SJ, Jeng JH, Chiang CP, Lau HP, Kok SH.

Head Neck. 2011 Sep;33(9):1366-71. doi: 10.1002/hed.21380.

PMID:
20310042
7.

Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: a retrospective survey of 347 cases.

Graziani F, Vescovi P, Campisi G, Favia G, Gabriele M, Gaeta GM, Gennai S, Goia F, Miccoli M, Peluso F, Scoletta M, Solazzo L, Colella G.

J Oral Maxillofac Surg. 2012 Nov;70(11):2501-7. doi: 10.1016/j.joms.2012.05.019.

PMID:
22883322
8.

Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases.

Mozzati M, Gallesio G, Arata V, Pol R, Scoletta M.

Oral Oncol. 2012 May;48(5):469-74. doi: 10.1016/j.oraloncology.2011.12.004.

PMID:
22265335
9.

Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws.

Kwon YD, Lee DW, Choi BJ, Lee JW, Kim DY.

Osteoporos Int. 2012 Nov;23(11):2721-5. doi: 10.1007/s00198-011-1882-9.

PMID:
22218418
10.

Adjuvant aqueous ozone in the treatment of bisphosphonate induced necrosis of the jaws: report of two cases and long-term follow-up.

Brozoski MA, Lemos CA, Da Graça Naclério-Homem M, Deboni MC.

Minerva Stomatol. 2014 Jan-Feb;63(1-2):35-41.

PMID:
24487948
11.

Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases.

Vescovi P, Merigo E, Manfredi M, Meleti M, Fornaini C, Bonanini M, Rocca JP, Nammour S.

Photomed Laser Surg. 2008 Feb;26(1):37-46. doi: 10.1089/pho.2007.2181.

PMID:
18248160
12.

The outcomes of conservative and surgical treatment of stage 2 bisphosphonate-related osteonecrosis of the jaws: a case series.

Jabbour Z, El-Hakim M, Mesbah-Ardakani P, Henderson JE, Albuquerque R Jr.

Int J Oral Maxillofac Surg. 2012 Nov;41(11):1404-9. doi: 10.1016/j.ijom.2012.05.012. Review.

PMID:
22704590
13.

Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.

Thumbigere-Math V, Sabino MC, Gopalakrishnan R, Huckabay S, Dudek AZ, Basu S, Hughes PJ, Michalowicz BS, Leach JW, Swenson KK, Swift JQ, Adkinson C, Basi DL.

J Oral Maxillofac Surg. 2009 Sep;67(9):1904-13. doi: 10.1016/j.joms.2009.04.051.

PMID:
19686928
14.

Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up.

Vescovi P, Manfredi M, Merigo E, Guidotti R, Meleti M, Pedrazzi G, Fornaini C, Bonanini M, Ferri T, Nammour S.

Photomed Laser Surg. 2012 Jan;30(1):5-13. doi: 10.1089/pho.2010.2955.

PMID:
22054203
15.
16.

Radical surgical treatment of bisphosphonate related osteonecrosis of the jaw.

Hewson I, Syme D, Bruscino-Raiola F.

Aust Dent J. 2012 Jun;57(2):227-30. doi: 10.1111/j.1834-7819.2012.01675.x.

17.

Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109 patients.

Watters AL, Hansen HJ, Williams T, Chou JF, Riedel E, Halpern J, Tunick S, Bohle G, Huryn JM, Estilo CL.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Feb;115(2):192-200. doi: 10.1016/j.oooo.2012.05.017.

PMID:
23036797
18.

Clinical treatment outcomes for 40 patients with bisphosphonates-related osteonecrosis of the jaws.

Lee LW, Hsiao SH, Chen LK.

J Formos Med Assoc. 2014 Mar;113(3):166-72. doi: 10.1016/j.jfma.2012.04.010.

19.

Ozone therapy in extractive surgery on patients treated with bisphosphonates.

Agrillo A, Sassano P, Rinna C, Priore P, Iannetti G.

J Craniofac Surg. 2007 Sep;18(5):1068-70.

PMID:
17912084
20.

Value of nonsurgical therapeutic management of stage I bisphosphonate-related osteonecrosis of the jaw.

Bodem JP, Kargus S, Engel M, Hoffmann J, Freudlsperger C.

J Craniomaxillofac Surg. 2015 Sep;43(7):1139-43. doi: 10.1016/j.jcms.2015.05.019.

PMID:
26116306
Items per page

Supplemental Content

Support Center